Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2197

1.

Updates to and quality of clinical practice guidelines for high-priority diseases in Japan.

Sasaki S, Imura H, Sakai K, Goto Y, Kitazawa K, Neff Y, Fujimoto S, Kaneyama J, Okumura A, Takahashi Y, Nakayama T.

Int J Qual Health Care. 2019 Nov 14. pii: mzz095. doi: 10.1093/intqhc/mzz095. [Epub ahead of print]

PMID:
31728518
2.

A case report of atopic myelitis mimicking anterior spinal artery syndrome.

Matsuzono K, Suzuki M, Fujimoto S.

Neurol Sci. 2019 Nov 11. doi: 10.1007/s10072-019-04117-6. [Epub ahead of print] No abstract available.

PMID:
31713189
3.

Epidemiological analysis of multicentric and unicentric Castleman disease and TAFRO syndrome in Japan.

Masaki Y, Kawabata H, Fujimoto S, Kawano M, Iwaki N, Kotani T, Nakashima A, Kurose N, Takai K, Suzuki R, Aoki S.

J Clin Exp Hematop. 2019 Nov 8. doi: 10.3960/jslrt.19021. [Epub ahead of print]

4.

Data on characteristics of reported cases of unilateral posterior reversible encephalopathy syndrome (PRES).

Ozawa T, Tanaka R, Nagaoka R, Anan Y, Kim Y, Matsuzono K, Mashiko T, Koide R, Shimazaki H, Ohtani K, Amano Y, Kawai K, Fujimoto S.

Data Brief. 2019 Oct 11;27:104648. doi: 10.1016/j.dib.2019.104648. eCollection 2019 Dec.

5.

Foxp3 Post-translational Modifications and Treg Suppressive Activity.

Deng G, Song X, Fujimoto S, Piccirillo CA, Nagai Y, Greene MI.

Front Immunol. 2019 Oct 18;10:2486. doi: 10.3389/fimmu.2019.02486. eCollection 2019. Review.

6.

Multicenter prospective analysis of stroke patients taking oral anticoagulants: The PASTA registry - Study design and characteristics.

Suda S, Iguchi Y, Fujimoto S, Yagita Y, Kono Y, Ueda M, Todo K, Kono T, Mizunari T, Yamazaki M, Kanzawa T, Okubo S, Kondo K, Nakajima N, Inoue T, Iwanaga T, Nakajima M, Imafuku I, Shibazaki K, Mishina M, Adachi K, Nomura K, Nakajima M, Yaguchi H, Okamoto S, Osaki M, Terasawa Y, Nagao T, Kimura K.

J Stroke Cerebrovasc Dis. 2019 Oct 29:104456. doi: 10.1016/j.jstrokecerebrovasdis.2019.104456. [Epub ahead of print]

PMID:
31676161
7.

Epidemiological Aspects of Escherichia albertii Outbreaks in Japan and Genetic Characteristics of the Causative Pathogen.

Masuda K, Ooka T, Akita H, Hiratsuka T, Takao S, Fukada M, Inoue K, Honda M, Toda J, Sugitani W, Narimatsu H, Ishioka T, Hirai S, Sekizuka T, Kuroda M, Morita Y, Hayashi T, Kimura H, Oishi K, Ohnishi M, Fujimoto S, Murakami K.

Foodborne Pathog Dis. 2019 Oct 11. doi: 10.1089/fpd.2019.2654. [Epub ahead of print]

PMID:
31603704
8.

Distinct spectrum of microRNA expression in forensically relevant body fluids and probabilistic discriminant approach.

Fujimoto S, Manabe S, Morimoto C, Ozeki M, Hamano Y, Hirai E, Kotani H, Tamaki K.

Sci Rep. 2019 Oct 4;9(1):14332. doi: 10.1038/s41598-019-50796-8.

9.

Cause-specific mortality in the general population with transient dipstick-proteinuria.

Nagai K, Yamagata K, Iseki K, Moriyama T, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Kasahara M, Shibagaki Y, Asahi K, Watanabe T.

PLoS One. 2019 Oct 2;14(10):e0223005. doi: 10.1371/journal.pone.0223005. eCollection 2019.

10.

Progression of hearing loss and choice of hearing aids by patients in their 60s, 70s, and 80s and older: experience in the Japanese super-aged era.

Maeda Y, Kariya S, Fujimoto S, Sugaya A, Kataoka Y, Nakagawa A, Tanaka S, Hosokawa N, Nishizaki K.

Acta Otolaryngol. 2019 Sep 27:1-6. doi: 10.1080/00016489.2019.1667531. [Epub ahead of print]

PMID:
31560242
11.

Usefulness of Transesophageal Echocardiography for Predicting Covert Paroxysmal Atrial Fibrillation in Patients with Embolic Stroke of Undetermined Source.

Ohya Y, Osaki M, Fujimoto S, Jinnouchi J, Matsuki T, Mezuki S, Kumamoto M, Kanazawa M, Tagawa N, Ago T, Kitazono T, Arakawa S.

Cerebrovasc Dis Extra. 2019 Sep 20;9(3):98-106. doi: 10.1159/000502713. [Epub ahead of print]

12.

A case of invasive pulmonary aspergillosis diagnosed by transbronchial lung biopsy during treatment for diabetic ketoacidosis in a type 1 diabetic patient.

Watanabe N, Saito K, Kiritani A, Fujimoto S, Yamanaka Y, Fujisaki I, Hosoda C, Miyagawa H, Seki Y, Kinoshita A, Takeda H, Endo Y, Kuwano K.

J Infect Chemother. 2019 Sep 18. pii: S1341-321X(19)30251-X. doi: 10.1016/j.jiac.2019.08.011. [Epub ahead of print]

PMID:
31542205
13.

KLF4 prevents epithelial to mesenchymal transition in human corneal epithelial cells via endogenous TGF-β2 suppression.

Fujimoto S, Hayashi R, Hara S, Sasamoto Y, Harrington J, Tsujikawa M, Nishida K.

Regen Ther. 2019 Sep 12;11:249-257. doi: 10.1016/j.reth.2019.08.003. eCollection 2019 Dec.

14.

A Prediction Model with Lifestyle in Addition to Previously Known Risk Factors Improves Its Predictive Ability for Cardiovascular Death.

Nishimoto M, Tagawa M, Matsui M, Eriguchi M, Samejima KI, Iseki K, Iseki C, Asahi K, Yamagata K, Konta T, Fujimoto S, Narita I, Kasahara M, Shibagaki Y, Moriyama T, Kondo M, Watanabe T, Tsuruya K.

Sci Rep. 2019 Sep 10;9(1):12953. doi: 10.1038/s41598-019-49003-5.

15.

Risk Factors for Post-Endoscopic Retrograde Pancreatography Pancreatitis: A Retrospective Chart Review in a Regional Hospital in Japan.

Shimamura T, Miyahara K, Takamori A, Hidaka H, Ito Y, Fujimoto S, Takedomi H, Tsuruoka N, Sakata Y, Eguchi Y, Node K, Noda T, Fujimoto K.

Digestion. 2019 Sep 5:1-6. doi: 10.1159/000501309. [Epub ahead of print] Review.

16.

Lower Diastolic Blood Pressure was Associated with Higher Incidence of Chronic Kidney Disease in the General Population Only in those Using Antihypertensive Medications.

Uchida D, Kido R, Kawarazaki H, Murasawa M, Ando A, Fujimoto S, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Konta T, Narita I, Kondo M, Kasahara M, Asahi K, Watanabe T, Shibagaki Y.

Kidney Blood Press Res. 2019;44(5):973-983. doi: 10.1159/000501828. Epub 2019 Sep 5.

17.

Ramen restaurant prevalence is associated with stroke mortality in Japan: an ecological study.

Matsuzono K, Mieno M, Fujimoto S.

Nutr J. 2019 Sep 4;18(1):53. doi: 10.1186/s12937-019-0482-y.

18.

Valproic acid promotes mature neuronal differentiation of adipose tissue-derived stem cells through iNOS-NO-sGC signaling pathway.

Okubo T, Fujimoto S, Hayashi D, Suzuki T, Sakaue M, Miyazaki Y, Tanaka K, Usami M, Takizawa T.

Nitric Oxide. 2019 Dec 1;93:1-5. doi: 10.1016/j.niox.2019.08.008. Epub 2019 Sep 1.

PMID:
31484045
19.

Cerebral venous sinus thrombosis associated with protein S deficiency during pregnancy: a case report.

Usui M, Ozawa T, Kim Y, Mashiko T, Matsuzono K, Maruyama K, Kokame K, Usui R, Koide R, Fujimoto S.

J Obstet Gynaecol. 2019 Sep 1:1-2. doi: 10.1080/01443615.2019.1606789. [Epub ahead of print] No abstract available.

PMID:
31475594
20.

Unilateral posterior reversible encephalopathy syndrome: A case report.

Ozawa T, Tanaka R, Nagaoka R, Anan Y, Kim Y, Matsuzono K, Mashiko T, Koide R, Shimazaki H, Ohtani K, Amano Y, Kawai K, Fujimoto S.

Clin Neurol Neurosurg. 2019 Oct;185:105493. doi: 10.1016/j.clineuro.2019.105493. Epub 2019 Aug 19. No abstract available.

PMID:
31470361
21.

Do We Have Adequate Flexion-Extension Radiographs for Evaluating Instability in Patients with Lumbar Spondylolisthesis?

Morita T, Yoshimoto M, Terashima Y, Tanimoto K, Iesato N, Ogon I, Oshigiri T, Teramoto A, Emori M, Takashima H, Hirota R, Fujimoto S, Yamashita T.

Spine (Phila Pa 1976). 2019 Aug 13. doi: 10.1097/BRS.0000000000003203. [Epub ahead of print]

PMID:
31415456
22.

Evidence for sympatric speciation in a Wallacean ancient lake.

Sutra N, Kusumi J, Montenegro J, Kobayashi H, Fujimoto S, Masengi KWA, Nagano AJ, Toyoda A, Matsunami M, Kimura R, Yamahira K.

Evolution. 2019 Sep;73(9):1898-1915. doi: 10.1111/evo.13821. Epub 2019 Aug 27.

PMID:
31407798
23.

The Effect of Dietary Supplementation of Crocetin for Myopia Control in Children: A Randomized Clinical Trial.

Mori K, Torii H, Fujimoto S, Jiang X, Ikeda SI, Yotsukura E, Koh S, Kurihara T, Nishida K, Tsubota K.

J Clin Med. 2019 Aug 7;8(8). pii: E1179. doi: 10.3390/jcm8081179.

24.

Adjustment of CT-fractional flow reserve based on fluid-structure interaction underestimation to minimize 1-year cardiac events.

Kato E, Fujimoto S, Kumamaru KK, Kawaguchi YO, Dohi T, Aoshima C, Kamo Y, Takamura K, Kato Y, Hiki M, Okai I, Okazaki S, Aoki S, Daida H.

Heart Vessels. 2019 Aug 7. doi: 10.1007/s00380-019-01480-4. [Epub ahead of print]

PMID:
31392411
25.

The potential role of follicular helper T cells in idiopathic multicentric Castleman disease with and without TAFRO syndrome.

Kurose N, Guo X, Shioya A, Mizutani KI, Kumagai M, Fujimoto S, Kawabata H, Masaki Y, Takai K, Aoki S, Nakamura S, Yamada S.

Pathol Res Pract. 2019 Oct;215(10):152563. doi: 10.1016/j.prp.2019.152563. Epub 2019 Jul 26.

PMID:
31358479
26.

Acute Aspirin Plus Cilostazol Dual Therapy for Noncardioembolic Stroke Patients Within 48 Hours of Symptom Onset.

Aoki J, Iguchi Y, Urabe T, Yamagami H, Todo K, Fujimoto S, Idomari K, Kaneko N, Iwanaga T, Terasaki T, Tanaka R, Yamamoto N, Tsujino A, Nomura K, Abe K, Uno M, Okada Y, Matsuoka H, Yamagata S, Yamamoto Y, Yonehara T, Inoue T, Yagita Y, Kimura K; ADS Investigators.

J Am Heart Assoc. 2019 Aug 6;8(15):e012652. doi: 10.1161/JAHA.119.012652. Epub 2019 Jul 26.

27.

Comparison of End-Tidal, Arterial, Venous, and Transcutaneous PCO2.

Fujimoto S, Suzuki M, Sakamoto K, Ibusuki R, Tamura K, Shiozawa A, Ishii S, Iikura M, Izumi S, Sugiyama H.

Respir Care. 2019 Oct;64(10):1208-1214. doi: 10.4187/respcare.06094. Epub 2019 Jul 23.

PMID:
31337742
28.

Design and rationale of the STroke secondary prevention with catheter ABLation and EDoxaban clinical trial in patients with non-valvular atrial fibrillation: The STABLED study.

Sakamoto Y, Nishiyama Y, Iwasaki YK, Daida H, Toyoda K, Kitagawa K, Okumura K, Kusano K, Hagiwara N, Fujimoto S, Miyamoto S, Otsuka T, Iguchi Y, Kanamaru T, Yamamoto T, Kaburagi J, Kimura T, Matsumoto T, Kimura K, Shimizu W; STABLED Study Investigators.

J Cardiol. 2019 Dec;74(6):539-542. doi: 10.1016/j.jjcc.2019.06.002. Epub 2019 Jul 20.

29.

Non-biogroup 1 or 2 Strains of the Emerging Zoonotic Pathogen Escherichia albertii, Their Proposed Assignment to Biogroup 3, and Their Commonly Detected Characteristics.

Murakami K, Maeda-Mitani E, Kimura H, Honda M, Ikeda T, Sugitani W, Konno T, Kawano K, Etoh Y, Sera N, Mizukoshi F, Saitoh T, Kawamura Y, Ishioka T, Ohnishi M, Oishi K, Fujimoto S.

Front Microbiol. 2019 Jul 5;10:1543. doi: 10.3389/fmicb.2019.01543. eCollection 2019.

30.

Diagnostic accuracy of 3D deep-learning-based fully automated estimation of patient-level minimum fractional flow reserve from coronary computed tomography angiography.

Kumamaru KK, Fujimoto S, Otsuka Y, Kawasaki T, Kawaguchi Y, Kato E, Takamura K, Aoshima C, Kamo Y, Kogure Y, Inage H, Daida H, Aoki S.

Eur Heart J Cardiovasc Imaging. 2019 Jun 23. pii: jez160. doi: 10.1093/ehjci/jez160. [Epub ahead of print]

PMID:
31230076
31.

Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?

Fujimoto S, Sakai T, Kawabata H, Kurose N, Yamada S, Takai K, Aoki S, Kuroda J, Ide M, Setoguchi K, Tsukamoto N, Iwao-Kawanami H, Kawanami T, Mizuta S, Fukushima T, Masaki Y.

Am J Hematol. 2019 Jun 10. doi: 10.1002/ajh.25554. [Epub ahead of print]

PMID:
31222819
32.

Endobronchial metastases 20 years after prostate cancer excision.

Hatakeyama Y, Yoshimura S, Ninomaru T, Fujimoto S, Takamiya R, Okamura K, Sano N, Ohnishi H.

Respir Med Case Rep. 2019 May 20;27:100858. doi: 10.1016/j.rmcr.2019.100858. eCollection 2019.

33.

The predictive factors affecting false positive in on-site operated CT-fractional flow reserve based on fluid and structural interaction.

Kawaguchi YO, Fujimoto S, Kumamaru KK, Kato E, Dohi T, Takamura K, Aoshima C, Kamo Y, Kato Y, Hiki M, Okai I, Okazaki S, Aoki S, Daida H.

Int J Cardiol Heart Vasc. 2019 May 11;23:100372. doi: 10.1016/j.ijcha.2019.100372. eCollection 2019 Jun.

34.

Osteosarcoma Manifesting Systemic Inflammation and Histological Features Mimicking Plasma Cell-type Castleman Disease.

Fujimoto S, Sakai T, Kawabata H, Kurose N, Yamada S, Doai M, Matoba M, Iwao-Kawanami H, Kawanami T, Mizuta S, Fukushima T, Mizumaki H, Yamaguchi M, Masaki Y.

Intern Med. 2019 Sep 1;58(17):2555-2560. doi: 10.2169/internalmedicine.2738-19. Epub 2019 Jun 7.

35.

Successful Desensitization with Crizotinib after Crizotinib-induced Liver Injury in ROS1-rearranged Lung Adenocarcinoma.

Ota T, Masuda N, Matsui K, Yamada T, Tanaka N, Fujimoto S, Fukuoka M.

Intern Med. 2019 Sep 15;58(18):2651-2655. doi: 10.2169/internalmedicine.2554-18. Epub 2019 Jun 7.

36.

Corrosion Generation and Cleaning Effect on Surgical Instruments with Attached Radiofrequency Identification Tags in Long-Term Usage.

Yamashita K, Miyabe S, Yamashita T, Kusuda K, Eba D, Tanaka K, Ishida S, Hosono M, Fujimoto S, Ino S, Ohta Y, Takase Y.

Surg Infect (Larchmt). 2019 Dec;20(8):665-671. doi: 10.1089/sur.2019.034. Epub 2019 Jun 7.

PMID:
31173540
37.

Novel mechanism of impaired metabolism-secretion coupling in β-cells: Loss of cytosolic adenosine triphosphate by leakage.

Fujimoto S.

J Diabetes Investig. 2019 Nov;10(6):1401-1404. doi: 10.1111/jdi.13094. Epub 2019 Jul 2.

38.

Inclusion of rehabilitation approach in Japanese clinical practice guidelines: a descriptive analysis.

Fujimoto S, Kobayashi M, Fujimoto S, Komukai K, Nakayama T.

J Phys Ther Sci. 2019 May;31(5):429-434. doi: 10.1589/jpts.31.429. Epub 2019 May 10.

39.

Fast eating is a strong risk factor for new-onset diabetes among the Japanese general population.

Kudo A, Asahi K, Satoh H, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Shibagaki Y, Kasahara M, Watanabe T, Shimabukuro M.

Sci Rep. 2019 Jun 3;9(1):8210. doi: 10.1038/s41598-019-44477-9.

40.

Clinical feasibility of auditory processing tests in Japanese older adults: a pilot study.

Fujimoto S, Maeda Y, Obuchi C, Uchida Y, Harashima T, Nishizaki K.

Acta Otolaryngol. 2019 Jul;139(7):625-631. doi: 10.1080/00016489.2019.1612532. Epub 2019 May 20.

PMID:
31104553
41.

Phase II trial of S-1 plus cisplatin combined with bevacizumab for advanced non-squamous non-small cell lung cancer (TCOG LC-1202).

Miyanaga A, Kubota K, Hosomi Y, Okuma Y, Minato K, Fujimoto S, Okamoto H, Satouchi M, Isobe H, Aono H, Takiguchi Y, Gemma A; Tokyo Cooperative Oncology Group.

Jpn J Clin Oncol. 2019 Aug 1;49(8):749-754. doi: 10.1093/jjco/hyz064.

PMID:
31070750
42.

Serum dickkopf-related protein 1 and sclerostin may predict the progression of chronic kidney disease in Japanese patients.

Hamada-Ode K, Taniguchi Y, Shimamura Y, Fujimoto S, Terada Y.

Nephrol Dial Transplant. 2019 May 5. pii: gfz078. doi: 10.1093/ndt/gfz078. [Epub ahead of print] No abstract available.

PMID:
31056712
43.

Characterisation of N-terminal pro-brain natriuretic peptide in dialysis patients and its reduced prognostic significance in the elderly.

Sato Y, Ishizaki Y, Aso K, Minakwa A, Toida T, Nishizono R, Kikuchi M, Inagaki H, Fujimoto S.

Sci Rep. 2019 Apr 29;9(1):6630. doi: 10.1038/s41598-019-43253-z.

44.

Changing clinical and molecular characteristics of hepatitis E virus infection in Mie Prefecture, Japan: Disappearance of indigenous subtype 3e strains.

Nakano T, Okano H, Takahashi M, Nagashima S, Shiraki K, Oya Y, Inoue H, Ohmori S, Tsukimoto M, Ishida S, Fujimoto S, Kobayashi M, Yamawaki M, Kumagai M, Ninomiya J, Maegawa T, Kojima Y, Araki J, Hamaoka S, Horiike S, Yoshimura H, Takeuchi K, Itoh K, Akachi S, Uraki S, Yamamoto N, Ogura S, Sugimoto K, Yoshikawa K, Hasegawa H, Iwasa M, Takei Y, Okamoto H.

Hepatol Res. 2019 Sep;49(9):1003-1014. doi: 10.1111/hepr.13357. Epub 2019 Jun 7.

PMID:
31026368
45.

Prolonged Tachycardia with Higher Heart Rate Is Associated with Higher ICU and In-hospital Mortality.

Hayashi M, Taniguchi A, Kaku R, Fujimoto S, Isoyama S, Manabe S, Yoshida T, Suzuki S, Shimizu K, Morimatsu H, Momota R.

Acta Med Okayama. 2019 Apr;73(2):147-153. doi: 10.18926/AMO/56650.

46.

Repetitive Episodic Isolated Vertigo in a Patient with Cerebellar Infarction.

Usui M, Mashiko T, Tsuda M, Suzuki M, Matsuzono K, Ozawa T, Kim Y, Shimazaki H, Koide R, Tanaka R, Fujimoto S.

J Stroke Cerebrovasc Dis. 2019 Jul;28(7):e98-e99. doi: 10.1016/j.jstrokecerebrovasdis.2019.03.051. Epub 2019 Apr 20.

PMID:
31010764
47.

Otologic Manifestations of Immunoglobulin G4-Related Disease.

Fujimoto S, Kim CH, Green T, Xu H.

Ear Nose Throat J. 2019 Apr 15:145561319842852. doi: 10.1177/0145561319842852. [Epub ahead of print] No abstract available.

PMID:
30987463
48.

Epidermal growth factor receptor-targeted molecular imaging of colorectal tumors: Detection and treatment evaluation of tumors in animal models.

Miyamoto Y, Muguruma N, Fujimoto S, Okada Y, Kida Y, Nakamura F, Tanaka K, Nakagawa T, Kitamura S, Okamoto K, Miyamoto H, Sato Y, Takayama T.

Cancer Sci. 2019 Jun;110(6):1921-1930. doi: 10.1111/cas.14020. Epub 2019 May 20.

49.

Pre- and Postdialysis Uric Acid Difference and Risk of Long-Term All-Cause and Cardiovascular Mortalities in Japanese Hemodialysis Patients; Miyazaki Dialysis Cohort Study.

Toida T, Sato Y, Komatsu H, Kitamura K, Fujimoto S.

Blood Purif. 2019;47 Suppl 2:50-55. doi: 10.1159/000496638. Epub 2019 Apr 3.

PMID:
30943478
50.

Infectious Virions of Bombyx Mori Latent Virus Are Incorporated into Bombyx Mori Nucleopolyhedrovirus Occlusion Bodies.

Tsukui K, Yagisawa C, Fujimoto S, Ogawa M, Kokusho R, Nozawa M, Kawasaki H, Katsuma S, Iwanaga M.

Viruses. 2019 Apr 1;11(4). pii: E316. doi: 10.3390/v11040316.

Supplemental Content

Loading ...
Support Center